Wealth Preservation Advisors, LLC Provectus Biopharmaceuticals, Inc. Transaction History
Wealth Preservation Advisors, LLC
- $140 Billion
- Q1 2025
A detailed history of Wealth Preservation Advisors, LLC transactions in Provectus Biopharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Preservation Advisors, LLC holds 52,000 shares of PVCT stock, worth $4,680. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52,000Holding current value
$4,680% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PVCT
# of Institutions
7Shares Held
229KCall Options Held
0Put Options Held
0-
Home Federal Bank Of Tennessee100KShares$9,0000.0% of portfolio
-
Atlas Wealth LLC Cincinnati, OH26.6KShares$2,3950.0% of portfolio
-
Lbmc Investment Advisors, LLC20KShares$1,8000.0% of portfolio
-
Academy Capital Management Inc Waco, TX20KShares$1,8000.0% of portfolio
-
Financial Symmetry Inc Raleigh, NC10.2KShares$9170.0% of portfolio
About PROVECTUS BIOPHARMACEUTICALS, INC.
- Ticker PVCT
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 419,496,992
- Market Cap $37.8M
- Description
- Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal ...